Mehdi Hassaniazad
Overview
Explore the profile of Mehdi Hassaniazad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
131
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ameri A, Farashahinejad M, Davoodian P, Safa O, Hassaniazad M, Parsaii M, et al.
Medicine (Baltimore)
. 2024 Sep;
103(22):e38289.
PMID: 39259072
Background: Ginger, a potent antiviral, anti-inflammatory, and antioxidant remedy, is a potential therapeutic option for COVID-19. However, there was not enough clinical evidence about ginger and COVID-19. We evaluated the...
2.
Fathi F, Ameri A, Safa O, Hassaniazad M, Fathalipour M
Medicine (Baltimore)
. 2024 Feb;
103(8):e35549.
PMID: 38394514
Coronavirus disease 2019 (COVID-19) vaccines are the most effective tools in managing the pandemic. However, the concern about these vaccines is the occurrence of unwanted adverse events (AEs). This study...
3.
Soltaninejad E, Hassan Z, Yekaninejad M, Hassaniazad M, Barahimi E, Samiei A, et al.
Int Immunopharmacol
. 2024 Jan;
128:111534.
PMID: 38237225
Background: The search for a potent anti-coronavirus therapy has remained an overwhelming task since the outbreak of COVID-19. Annual SZ is a novel formulation of artemisinin and its derivatives. We...
4.
Hosseini Z, Azizi K, Moghadami M, Hassaniazad M, Shafiei R, Rezaee E, et al.
J Arthropod Borne Dis
. 2023 Oct;
17(2):128-137.
PMID: 37822760
Background: Asymptomatic malaria is a major challenge to be addressed in the implementation of the malaria elimination program. The main goal of the malaria surveillance system in the elimination phase...
5.
Barahimi E, Basham A, Evazi E, Hassaniazad M, Heidari B, Mazaheri M
CEN Case Rep
. 2023 Sep;
13(3):149-153.
PMID: 37676477
We report co-occurrence of emphysematous cystitis and emphysematous pyelonephritis (EC/EPN) in a 64-year-old female with poor-controlled diabetes mellitus (DM) that presented with flank pain, fever, and hematuria that turned out...
6.
Estabraghnia Babaki H, Jarineshin H, Saljoughi F, Hassaniazad M, Rafati S, Sohrabipour S
Tanaffos
. 2023 Aug;
21(4):455-465.
PMID: 37583773
Background: The clinical characteristics of COVID-19 are diverse from a simple common cold symptom to acute respiratory distress syndrome (ARDS). In the present study, we attempted to identify the associated...
7.
Baniasadi T, Hassaniazad M, Niakan Kalhori S, Shahi M, Ghazisaeedi M
BMC Med Inform Decis Mak
. 2023 Jun;
23(1):103.
PMID: 37268995
Background: Many early signs of Surgical Site Infection (SSI) developed during the first thirty days after discharge remain inadequately recognized by patients. Hence, it is important to use interactive technologies...
8.
Farshidi N, Ghaedi T, Hassaniazad M, Eftekhar E, Gouklani H, Farshidi H, et al.
Microb Pathog
. 2022 Aug;
171:105736.
PMID: 36030048
From December 2019, the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was started as a cluster of pneumonia cases in Wuhan, Hubei Province, China. The disturbing statistics of...
9.
Hassaniazad M, Farshidi H, Gharibzadeh A, Bazram A, Khalili E, Noormandi A, et al.
J Med Virol
. 2022 Mar;
94(7):3184-3191.
PMID: 35292989
Favipiravir (FVP), lopinavir/ritonavir (LPV/RTV), and interferon-beta (INF-beta) are considered as potential treatments for COVID-19. We examined the efficacy and safety of FVP and INF-beta compared to LPV/RTV and INF-beta combinations...
10.
Ahmadi I, Estabraghnia Babaki H, Maleki M, Jarineshin H, Kaffashian M, Hassaniazad M, et al.
Int J Endocrinol
. 2022 Mar;
2022:4280691.
PMID: 35251166
There is some indication that coronavirus disease 2019 (COVID-19) causes hypothalamic-pituitary-adrenal axis insufficiency. However, being on glucocorticoids makes it difficult to fully investigate this axis, especially in patients with severe...